News • I-View software

Mammography fusion enhanced by contrast

Using an iodinated contrast agent, I-View software on the Hologic tomosynthesis system enables the user to image the functional 2-D contrast uptake and the morphological mammography images in rapid sequence and combine these three image sets into a single co-registered study.

Photo

This image set from an iodine contrast mammography study was acquired under a single breast compression. The lesion pointed to with the straight arrow can be identified with the 2-D image (left), although the tomosynthesis slice (centre) shows the distortion associated with the lesion more clearly, and there is also iodine contrast uptake in the lesion in the contrast image (right).

The lesion pointed to with the curved arrow has strong iodine uptake, but this cannot be identified easily in the dense areas of the non-contrast mammographic image seen here.

In this unique study, the 2-D contrast image can identify potential lesions based on their physiological state, which can cause increased contrast agent uptake. The standard 2-D and 3-D Mammography images can then be reviewed for morphological information.

Landmarks from the mammography images are also helpful for follow-up tomosynthesis guided biopsy procedures.

01.03.2016

Read all latest stories

Related articles

Photo

Article • Key findings of latest survey

Women’s health: solutions for a growing problem

Awareness of the importance of women’s health is on the rise, but many challenges remain: At ECR 2024 in Vienna, we spoke with Hologic about their continued evaluation of healthcare efforts for…

Photo

Article • Digital breast tomosynthesis

Transforming breast screening: The role of AI in improving reading workflow

While having more centers adopt digital breast tomosynthesis (DBT) for breast cancer screenings into their practice is a positive change, it also presents some challenges for…

Photo

Article • Supplemental imaging

The next breast screening advancement: Contrast-enhanced mammography

With the recent recommendation changes from the European Council in 2022, how radiologists screen for breast cancer is changing. Mammography has long been an essential technology in screening for…

Related products

Subscribe to Newsletter